Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 10412-93-8 | MDL No. : | MFCD00461336 |
Formula : | C10H10N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JQVMRGYDSQFFJC-UHFFFAOYSA-N |
M.W : | 174.20 | Pubchem ID : | 668298 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.58 |
TPSA : | 52.89 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.59 cm/s |
Log Po/w (iLOGP) : | 1.32 |
Log Po/w (XLOGP3) : | 1.09 |
Log Po/w (WLOGP) : | 1.06 |
Log Po/w (MLOGP) : | 0.91 |
Log Po/w (SILICOS-IT) : | 1.58 |
Consensus Log Po/w : | 1.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.68 |
Solubility : | 3.6 mg/ml ; 0.0207 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.79 |
Solubility : | 2.81 mg/ml ; 0.0161 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.29 |
Solubility : | 0.0895 mg/ml ; 0.000514 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With sodium ethanolate In ethanol at 20℃; for 1 h; | General procedure: A mixture of a solution of sodium ethoxide (0.1 mmol) in ethanol (3 mL), ethyl cyanoacetate (10 mmol) and amine (10 mmol) was stirred at room temperature. The reaction time is 1 h for primary amines and 24 h for secondary amine 2d. The precipitate obtained was separated by filtration, washed with diethylether and recrystallised in ethanol to provide a white solid of cyanoacetamides. |
75% | at 20 - 25℃; for 24 h; | General procedure: A mixture of ethyl cyanoacetate (1.1g, 10mmol) and amine (11mmol) was stirred at 20-25°C. After 24 h, the Precipitate will be filtered and washed with cold diethyl ether, then dried on vacuum. |
68% | for 4 h; Heating / reflux | EXAMPLE 1; General Methodfor Synthesis of Compounds; N- (Phenylalkyl) cinnamides were prepared by the following general procedure. Benzylamine (3. 0g, 28 mmol) and ethyl cyanoacetate (4. 7 g, 42 mmol) in acetonitrile (20 mL) was stirred and reflux for 4 hr. Benzylamine in this general procedure can be replaced by any other substituents depicted as R3 above. The solvent was removed in vacuo to give an oil which solidified upon standing. Precipitation (EtOAc) resulted in 3.28g (68percent) of an off-white powder corresponding to N-benzylcyanoacetamide as an intermediate. A mixture of N- benzylcyanomethylamide (1.3, 7.5 mmol), 3,4-dihydroxybenzaldehyde (1.1 g, 8.2 mmol), and piperidine (catalytic, 5 drops) was stirred at reflux for 3 hr. Flash chromatography (EtOAc) followed by two recrystalizations (H20/EtOH) yielded product as a white powder 0.8g (36percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; | To stirred solution of diisopropylethyl amine (506 μl, 3 mmol) and benzylamine (327 μl, 3 mmol) in DMF was added cyanoacetic acid (85 mg, 1 mmol), EDC (625 mg, 3 mmol), and HOBt (208 mg, 1.5 mmol). The reaction was stirred room temperature overnight. The reaction was then diluted with ether and the organic layer was washed twice with 1N HCl and once with brine. The organic layer was dried over sodium sulfate, filtered and concentrated by rotary evaporation. The clear residue was lyophilized from benzene to give 24 mg (14percent yield) of an off-white powder that needed no further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | for 3 h; Heating / reflux | EXAMPLE 1; General Methodfor Synthesis of Compounds; N- (Phenylalkyl) cinnamides were prepared by the following general procedure. Benzylamine (3. 0g, 28 mmol) and ethyl cyanoacetate (4. 7 g, 42 mmol) in acetonitrile (20 mL) was stirred and reflux for 4 hr. Benzylamine in this general procedure can be replaced by any other substituents depicted as R3 above. The solvent was removed in vacuo to give an oil which solidified upon standing. Precipitation (EtOAc) resulted in 3.28g (68percent) of an off-white powder corresponding to N-benzylcyanoacetamide as an intermediate. A mixture of N- benzylcyanomethylamide (1.3, 7.5 mmol), 3,4-dihydroxybenzaldehyde (1.1 g, 8.2 mmol), and piperidine (catalytic, 5 drops) was stirred at reflux for 3 hr. Flash chromatography (EtOAc) followed by two recrystalizations (H20/EtOH) yielded product as a white powder 0.8g (36percent). |
[ 926307-99-5 ]
1-Oxoisoindoline-5-carbaldehyde
Similarity: 0.78
[ 1260664-94-5 ]
3-Oxoisoindoline-5-carbaldehyde
Similarity: 0.78
[ 1422057-35-9 ]
5-(Aminomethyl)isoindolin-1-one hydrochloride
Similarity: 0.77
[ 1261726-80-0 ]
3-Oxoisoindoline-5-carbonitrile
Similarity: 0.78
[ 769-28-8 ]
4,6-Dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
Similarity: 0.69